Largest Experience of Safety and Efficacy of Patiromer in Solid Organ Transplant

Largest Experience of Safety and Efficacy of Patiromer in Solid Organ Transplant

Bibliographic Details
Main Authors:	Kendra Schnelle, PharmD, Holli Winters, PharmD, Todd Pesavento, MD, Priyamvada Singh, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2020-09-01
Series:	Transplantation Direct
Online Access:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001037

Similar Items

Efficacy of Curcuma for Treatment of Osteoarthritis
by: Kimberly Perkins PharmD, et al.
Published: (2017-01-01)

Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis
by: Dhan Bahadur Shrestha, MD Resident Physician, et al.
Published: (2021-01-01)

Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review
by: Laura M. Koppen PharmD, et al.
Published: (2017-10-01)

Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
by: Michael E. Plazak, PharmD, et al.
Published: (2021-02-01)

COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice
by: Ashish Kataria, MD, et al.
Published: (2020-08-01)

Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review
by: Thangavel Mahalingam Vijayakumar, M.Pharm, PhD, et al.
Published: (2017-01-01)

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis
by: Benjamin Miao PharmD, et al.
Published: (2019-05-01)

Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
by: Shahideh Amini, PharmD, et al.
Published: (2020-01-01)

Daptomycin Experience in Patients with Human Immunodeficiency Virus and Resistant Gram-Positive Infections
by: Jihad Slim MD, et al.
Published: (2015-05-01)

Safety and Efficacy of Using Fracture Tables for Prosthetic Hip Dislocations
by: Marc-Antoine Tremblay, MD, et al.
Published: (2021-06-01)

The Effect of Pharmacist Intervention on Diabetes Screening Promotion and Education in a Geriatric Population
by: Ann Ryan-Haddad, PharmD, et al.
Published: (2012-01-01)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
by: Becky S. Linn PharmD, et al.
Published: (2021-10-01)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
by: Dana R. Pierce, PharmD, et al.
Published: (2021-06-01)

Rapid Reduction in HIV Viral Load in Late Pregnancy with Raltegravir
by: Agnes Cha PharmD, et al.
Published: (2013-09-01)

Critical Analysis of Apixaban Dose Adjustment Criteria
by: Anh Vu PharmD, et al.
Published: (2021-06-01)

Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit
by: Kimberly A. Redic, PharmD, et al.
Published: (2017-06-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
by: Ashley Branham, PharmD, et al.
Published: (2010-01-01)

Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults
by: Arzo Hamidi, PharmD, et al.
Published: (2021-03-01)

Over-the-Counter Medication Use, Perceived Safety, and Decision-Making Behaviors in Pregnant Women
by: Katie L. Kline, Pharm.D. Candidate 2011, et al.
Published: (2011-01-01)

Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone
by: Edmund Huang, MD, et al.
Published: (2020-08-01)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
by: Rachel N. Goldberg PharmD, et al.
Published: (2021-02-01)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
by: Kristen L. Bunnell PharmD, et al.
Published: (2018-01-01)

Derivation and Validation of Age- and Body Mass Index-Adjusted Weight-Based Unfractionated Heparin Dosing
by: James W. Schurr PharmD, et al.
Published: (2019-03-01)

Safety and Tolerability of Stribild in the Southeast United States
by: Caroline Boyd Derrick PharmD, BCPS, et al.
Published: (2016-09-01)

Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study
by: Amina A. Alkhalaf, PharmD, et al.
Published: (2021-10-01)

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

Hemodynamic Effects of an Increased Midodrine Dosing Frequency
by: Shea A. Macielak, PharmD, et al.
Published: (2021-04-01)

The Study of the Efficacy of N-Acetylcysteine for the Prevention of Contrast Induced Nephropathy in Normal Renal Functioning Patients Undergoing Coronary Angiography
by: A. Mohseni, M.D., et al.
Published: (2007-01-01)

Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment
by: Clara Ting PharmD, et al.
Published: (2021-01-01)

Sharing Community Engagement in Pharmacy – An Invitation
by: Todd D. Sorensen, Pharm.D., et al.
Published: (2011-01-01)

Implementing a Pharmacist-Led Medication Management Pilot to Improve Care Transitions
by: Rachel Root, PharmD, MS, et al.
Published: (2012-01-01)

Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients
by: Douglas Buckheit PharmD, et al.
Published: (2021-06-01)

Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Jessica J. Skradski, PharmD, et al.
Published: (2012-01-01)

Lifestyle Medicine-Related Cardiovascular Risk Factor Changes in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Cultivation and Implementation of Community-Engaged Pharmacy Services in a Free Clinic to Enhance Care for the Medically Underserved
by: Emmeline Tran, Pharm.D. Candidate, et al.
Published: (2013-01-01)

Pharmacist-Driven Management of Chemotherapy Induced Nausea and Vomiting in Hospitalized Adult Oncology Patients. A Retrospective Comparative Study
by: Ramy Elshaboury, PharmD, et al.
Published: (2011-01-01)

Nutritional supplements for the prevention of diabetes mellitus and its complications
by: Sharon Yeung, PharmD Candidate, et al.
Published: (2018-12-01)

Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
by: Michael Behal, PharmD, et al.
Published: (2021-07-01)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
by: Jennifer S. Husson, MD, MPH, et al.
Published: (2017-12-01)